Understanding the Cimzia Copay Card
Cimzia (certolizumab pegol) is a biologic medication used to treat rheumatoid arthritis, Crohn’s disease, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Manufactured by UCB, Cimzia carries a list price of roughly $5,800 to $6,500 per month, placing it firmly in the specialty drug category. A Cimzia copay card from UCB can reduce your out-of-pocket cost to as little as $0 per dose if you have commercial insurance, making an otherwise unaffordable therapy accessible.
More than 70% of commercially insured patients who use biologic medications face copays exceeding $100 per fill, according to IQVIA data. The Cimzia copay card, formally known as the CIMplicity Copay Program, is designed to absorb most or all of that cost. This guide explains how the card works, who qualifies, and what to do if you do not.
How the Cimzia Copay Card Works
The CIMplicity Copay Program functions like a secondary insurance payment. When you fill your Cimzia prescription, the pharmacy bills your primary insurance first. Whatever copay, coinsurance, or deductible amount remains as your responsibility, the copay card covers, up to the program’s annual maximum.
In 2026, the program offers up to $15,000 per calendar year in copay assistance. For most commercially insured patients, this is enough to cover the entire year’s out-of-pocket costs. If your plan charges a $200 monthly copay for Cimzia, for example, the copay card would cover $2,400 over 12 months, well within the $15,000 cap.
Patients who face higher cost-sharing, such as coinsurance of 30% on a $6,000 prescription ($1,800 per fill), may reach the annual limit faster. In those cases, UCB’s patient support team can discuss supplemental assistance options.
Eligibility Requirements
The Cimzia copay card has specific eligibility criteria:
- Commercial insurance required: You must have private health insurance that covers Cimzia. The card covers your remaining out-of-pocket share.
- Not for government insurance: Patients with Medicare (including Part D and Medicare Advantage), Medicaid, TRICARE, VA benefits, or any other federal or state healthcare program are ineligible. Federal anti-kickback laws prohibit manufacturer copay assistance for government-insured patients.
- U.S. residency: You must live in the United States or its territories.
- Valid prescription: You must have a valid prescription for Cimzia from a licensed prescriber.
There is no income requirement for the copay card program. If you have qualifying commercial insurance, you are eligible regardless of your household income.
How to Enroll
Enrolling in the CIMplicity Copay Program takes just a few minutes.
Online: Visit the official Cimzia website (cimzia.com) and navigate to the savings section. Complete the enrollment form with your personal information, insurance details, and prescriber name. You will receive your copay card number immediately.
By phone: Call UCB’s CIMplicity support line at 1-866-424-6942. A representative can enroll you over the phone and provide your card information on the spot.
Through your specialty pharmacy: Many specialty pharmacies that dispense Cimzia are familiar with the CIMplicity program and can initiate enrollment during your first fill. Ask your pharmacist whether they can apply the copay card automatically.
Once enrolled, present your copay card information each time you fill your prescription. The pharmacy processes it alongside your insurance claim, and the card covers the remaining balance up to the program maximum.
What the Copay Card Does Not Cover
While the Cimzia copay card is valuable, it has limitations you should understand.
Deductible accumulator programs: Some insurance plans have implemented copay accumulator or maximizer programs that prevent manufacturer copay assistance from counting toward your annual deductible and out-of-pocket maximum. Under these plans, you might use up your copay card benefits early in the year and then face full cost-sharing for the remainder. Check with your insurer to determine whether your plan uses an accumulator. If it does, UCB’s CIMplicity team can help you strategize.
Non-covered services: The copay card only applies to the cost of Cimzia itself. It does not cover administration fees, office visit copays, or lab work associated with your treatment.
Plan denials: If your insurance denies coverage for Cimzia entirely (as opposed to covering it with a high copay), the copay card cannot help because there is no insurance claim to supplement. In this situation, UCB’s patient assistance program may be able to provide Cimzia at no cost.
Savings Options for Medicare Patients
Because Medicare patients cannot use the Cimzia copay card, they need alternative strategies to manage costs.
Medicare Part D Extra Help: The Extra Help (Low-Income Subsidy) program reduces premiums, deductibles, and copays for qualifying beneficiaries. If you qualify for full Extra Help, your copay for Cimzia could drop to $11.20 per fill in 2026.
UCB Patient Assistance Program: UCB offers a separate patient assistance program for patients who are uninsured or cannot afford their medication even with insurance. Medicare patients who face prohibitive cost-sharing may qualify. Contact UCB at 1-866-424-6942 for details.
State pharmaceutical assistance programs (SPAPs): Several states operate programs that help Medicare beneficiaries with high drug costs. These vary by state and may provide additional subsidies on top of Part D coverage.
Foundation assistance: Independent charitable foundations, such as the HealthWell Foundation and the Patient Access Network (PAN) Foundation, sometimes offer copay assistance for Cimzia. Funding availability varies and may be limited, so apply early.
Cimzia vs. Biosimilar Alternatives
As of 2026, no biosimilar for Cimzia has been approved by the FDA. Unlike Humira, which now has multiple biosimilars on the market, Cimzia’s unique PEGylated structure has made biosimilar development more complex. This means that for the foreseeable future, the brand-name product is the only option.
If cost remains a barrier even with the copay card, discuss therapeutic alternatives with your rheumatologist or gastroenterologist. Other biologics in the same TNF-inhibitor class, such as adalimumab (Humira) biosimilars, may be available at lower cost. However, switching biologics should only be done under medical supervision, as individual response varies significantly.
Tips for Maximizing Your Copay Card Benefits
These strategies help you get the most from your Cimzia copay card:
Enroll before your first fill. Having the copay card active from day one ensures your first dose is covered. Retroactive reimbursement is sometimes possible but adds hassle.
Understand your plan’s benefit design. Know your deductible, coinsurance rate, and whether your plan uses a copay accumulator. This information lets you forecast when you might exhaust the card’s annual benefit and plan accordingly.
Ask about 90-day fills. Some specialty pharmacies offer 90-day supplies that can simplify refills and potentially affect how the copay card is applied. Discuss this with your pharmacy and UCB support.
Track your usage. Keep a record of how much copay assistance you have used throughout the year. If you approach the $15,000 limit, contact UCB’s CIMplicity team early to explore supplemental assistance before you hit the cap.
Frequently Asked Questions
Can I use the Cimzia copay card at any pharmacy?
The card works at most specialty pharmacies that dispense Cimzia. Because Cimzia is a specialty medication, it is typically filled through specialty pharmacy channels rather than a standard retail pharmacy. Confirm with your pharmacy that they accept UCB copay cards.
Does the copay card cover the loading dose?
Yes. The copay card covers all FDA-approved doses of Cimzia, including the initial loading dose (400 mg at weeks 0, 2, and 4) and the maintenance dose (200 mg every two weeks or 400 mg every four weeks). The loading dose period is often the most expensive, so having the card active from the start is important.
What happens if I switch insurance plans?
You may need to update your information with the CIMplicity program when your insurance changes. Contact UCB at 1-866-424-6942 to report the change and confirm continued eligibility. If you switch to a government plan like Medicare, you will no longer qualify for the copay card and should explore alternative assistance.
Is there a generic for Cimzia?
No. As a biologic medication, Cimzia cannot have a traditional generic. Instead, competitors would need to develop a biosimilar, which requires separate FDA approval. No Cimzia biosimilar has been approved as of 2026. For more about how biosimilars compare to brand-name biologics, see our Humira biosimilar guide.
Start Saving on Cimzia Today
If you have commercial insurance and a valid prescription for Cimzia, the CIMplicity Copay Program can eliminate or drastically reduce your out-of-pocket costs. Enroll at cimzia.com or call 1-866-424-6942 before your next fill. Medicare patients should explore Extra Help and UCB’s patient assistance program. For a broader look at prescription savings strategies, visit our healthcare costs guide.